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Abstract We identified increased expression and redistribu-
tion of the intracellular protein 60-kDa human heat shock
protein (hHSP60) (HSPD1) to the cell surface in human endo-
thelial cells subjected to classical atherosclerosis risk factors
and subsequent immunologic cross-reactivity against this high-
ly conserved molecule, as key events occurring early in the
process of atherosclerosis. The present study aimed at investi-
gating the role of infectious pathogens as stress factors for
vascular endothelial cells and, as such, contributors to early
atherosclerotic lesion formation. Using primary donor-
matched arterial and venous human endothelial cells, we show
that infection with Chlamydia pneumoniae leads to marked
upregulation and surface expression of hHSP60 and adhesion
molecules. Moreover, we provide evidence for an increased
susceptibility of arterial endothelial cells for redistribution of
hHSP60 to the cellular membrane in response to C. pneumo-
niae infection as compared to autologous venous endothelial
cells. We also show that oxidative stress has a central role to
play in endothelial cell activation in response to chlamydial
infection. These data provide evidence for a role ofC. pneumo-
niae as a potent primary endothelial stressor for arterial endo-
thelial cells leading to enrichment of hHSP60 on the cellular
membrane and, as such, a potential initiator of atherosclerosis.
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Introduction
There is increasing evidence from clinical and experimental
studies for a causative role of infection and inflammation in
initiation and progression of atherosclerosis (Ross 1999;
Hansson 2001; Libby 2002; Wick et al. 2004). Our
research group formulated the “Autoimmune Concept of Ath-
erosclerosis,” experimental and clinical evidence for which
was provided by data gathered from our and other laboratories
over the past several years (Wick et al. 2001, 2004; Grundtman
et al. 2011). At the heart of this concept lies the finding that
stressed endothelial cells become the target of pre-existing
innate and adaptive cellular and humoral immunity against
eukaryotic cross-reactive HSP60 epitopes due to earlier infec-
tions or vaccinations, as well as bona fide autoimmunity
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against biochemically altered autologous HSP60 (Xu et al.
1993a; b; 1994; 2000; Grundtman and Wick 2011). At a
molecular level, we and others have shown that hHSP60 is
expressed as a first response, serving as an immunological
danger signal in endothelial cells subjected to classical
risk factors for atherosclerosis including cigarette smoke, ox-
idative stress, and oxidized LDL, rendering the cells a target of
pre-existing cross-reactive autoimmunity (Xu et al. 1994;
Amberger et al. 1997; Shi and Tokunaga 2004; Henderson et
al. 2008; Kreutmayer et al. 2011). Clinically, a significant
correlation between antibacterial HSP60 antibody levels and
prevalent carotid atherosclerosis was observed, and the pres-
ence of human and chlamydial antibodies to HSP60 was
identified as an independent risk factor for coronary athero-
sclerosis (Xu et al. 1993a; b; 1999). Severely aggravated
lesion formation and enrichment of HSP60-reactive T cells
within atherosclerotic lesions in rabbits and mice by immuni-
zation with recombinant HSP65 further indicate the role of
HSP60 as a putative antigen, initiating and maintaining vas-
cular inflammation (Xu et al. 1992; George et al. 1999).
According to our concept of an autoimmune basis of athero-
sclerosis, the lifelong burden of being subjected to infectious
agents, such as Chlamydia pneumoniae, would go hand-in-
hand with an increased risk of developing immunologic cross-
reactivity against autologous HSP60 (Mayr et al. 1999a). In a
previous study, it was shown that chlamydial HSP60
(cHSP60) antibodies cross-react with hHSP60 counterparts
and mediate cytotoxicity to stressed endothelial cells. More-
over, there was a strong correlation between cross-reactive
anti-HSP60 and anti-C. pneumoniae antibody titers (Mayr et
al. 1999b). In terms of epidemiology, population-based stud-
ies show that most individuals get infected with C. pneumo-
niae before the age of 20, and specific antibodies against C.
pneumoniae are found in more than 70 % of people aged 50
and above (Grayston 2000). Based on increased serum anti-
body titers against this agent in patients with coronary heart
disease, Saikku et al. (1988) suggested a possible relationship
between C. pneumoniae infection and atherosclerosis. This
finding was confirmed by subsequent population-based stud-
ies that found a strong correlation between the risk for coro-
nary heart disease and detection ofC. pneumoniae in coronary
arterial tissue (Jackson et al. 1997; Yamashita et al. 1998).
Remarkably, while more than 50% of coronary plaque lesions
harbor C. pneumoniae, the pathogen has rarely been detected
in healthy vascular tissue (Shi and Tokunaga 2004). Experi-
mentally, it has been shown that the major pro-inflammatory
transcription factor NF-κB is upregulated in endothelial cells
subsequent to C. pneumoniae infection, leading to increased
secretion of interleukin (IL)-1, IL-8, and monocyte chemotac-
tic protein 1 (MCP-1) (Hogdahl et al. 2008).
In summary, these lines of evidence support the notion that
chlamydial infection is a potent contributor to vascular in-
flammation. However, classical experimental protocols used
centrifugation (Dechend et al. 2003) of the endothelial cells
together with the C. pneumoniae infective particles (elemen-
tary bodies) to enable productive infection of the target cells.
As these treatments themselves represent stressful me-
chanical conditions that might induce a stress reaction
in endothelial cells, they are unsuitable protocols for studying
C. pneumoniae-induced stressor effects (Krüll et al. 1999; Shi
and Tokunaga 2004). In order to have a noninvasive experi-
mental setting avoiding an additional centrifugation step,
we used the CV6 strain of C. pneumoniae that shows a
special tropism for endothelial cells. Moreover, in the
present study, we employed human umbilical vein endothelial
cells (HUVECs) as well as primary adult arterial and venous
endothelial cells (AECs and VECs), from the same donors.
Thus, we were able to delineate the susceptibility of AECs and
VECs to a C. pneumoniae-induced pro-inflammatory pheno-
type while avoiding a confounding effect inherent to the
genetic variability of primary cells derived from different
donors. In particular, we set out to investigate the threshold
for surface expression of hHSP60 in primary AECs as com-
pared to autologous VECs in response to C. pneumoniae
infection. Here, we identify chlamydial infection as an inducer
of hHSP60 expression in primary endothelial cells more po-
tent than any of the classical endothelial stress factors. More-
over, we provide evidence for a particularly increased
susceptibility of AECs for surface expression of hHSP60 as
compared to autologous VECs.
Materials and methods
Culture of C. pneumoniae
The cardiovascular C. pneumoniae strain CV-6, a coronary
artery isolate, was grown on HEp-2 cell monolayers as de-
scribed (Gieffers et al. 2001). Absence of mycoplasma was
shown by PCR (Stratagene, Santa Clara, CA, USA).
Cell culture
HUVECs were isolated from umbilical cords obtained with
informed consent from the Department of Gynecology and
Obstetrics, Innsbruck Medical University. AECs and VECs
were isolated from the iliac arteries and veins of transplant
donors obtained from the Clinic of Visceral, Transplant and
Thorax Surgery, Innsbruck Medical University. The isolation
and use of human tissues for these experiments has been
approved by the Ethics Committee of Innsbruck Medical
University (resolution numbers UN2979 and AM2670c).
Cells were isolated by enzymatic detachment, using collage-
nase as described elsewhere (Amberger et al. 1997), and
subsequently cultured in 0.2 % gelatin-coated (Sigma-
Aldrich, St. Louis, MO, USA) polystyrene flasks (Becton
260 S. Kreutmayer et al.
Dickinson, Meylan Cedex, France) in Endothelial Cell Basal
Medium-2 (EBM-2 containing EGM-2 SingleQuots supple-
ments; Lonza, Basel, Switzerland) including 2 % fetal bovine
serum and growth factors (Lonza) in a humidified atmosphere
of 5 % CO2. The medium was replaced by RPMI without
phenol red and antibiotics, supplemented with 10 % FCS and
5 % L-glutamine (Lonza) prior to the addition of the infectious
chlamydial particles, to avoid diminished infectivity due to
antibiotic compounds and because phenol red is an antioxi-
dant (Lewinska et al. 2007) which may preclude assays on the
oxidative state of cells. Chemical reagents were purchased
from Merck (Darmstadt, Germany) unless stated otherwise
and were of analytical grade quality.
Infection of endothelial cells with C. pneumoniae
Endothelial cells were cultivated to a maximum of six pas-
sages. To allow for an optimal comparison between
AECs and VECs, cells from one donor in one enclosed
experimental setting were used. Endothelial cells were
infected at 80 % confluence at a low dose of 1.5 inclusion
forming units per cell.
Real-time PCR (RT-PCR)
RT-PCR was performed using the LightCycler FastStart
DNA Master SYBR Green kit (Roche) on the LightCycler
1.0 system (Roche). Synthesis of the first strand of cDNA
from total RNA (500 ng) was achieved using First Strand
cDNA Synthesis Kit (Roche) according to the manufac-
turer’s recommendations. The cDNA was diluted tenfold
before equal amounts were added to duplicate (or triplicate)
RT-PCR reactions. To ensure the highest possible accuracy,
a master mix containing all reagents except for the primers
was created; the primers for the gene of interest or a house-
keeping gene was added directly to the glass capillary.
Primer pairs are given in Table 1. Each reaction proceeded
for 40 amplification cycles, followed by a melting curve
analysis to ensure the specificity of each reaction, controlled
by the supplied LightCycler software (version 3.5, Roche).
Crossing point and melting curve analyses for each reaction
were also performed using the LightCycler software.
Western blot analysis
Total protein extracts of C. pneumoniae-infected HUVECs
and controls were obtained using standard NP-40 cell lysis
buffer (50 mM Tris/HCl, pH 8, 150 mM NaCl, 1 % NP-40).
The protein content was determined with Bradford reagent
(Bio-Rad, Hercules, CA, USA) following the manufac-
turer’s protocol. Equal amounts of protein in loading buffer
(200 mM Tris/HCl, pH 6.8, 400 mM DTT, 8 % SDS, 0.4 %
bromophenol blue, and 50 % glycerol) were loaded onto
12 % Tris/Glycine SDS-PAGels, purchased from Lonza, and
run at 25 mA for 1 h. Proteins were blotted to a nitrocellu-
lose membrane (Schleicher & Schuell, Dassel, Germany),
and hHSP60 was stained using a mouse anti-human HSP60
antibody (clone II-13, prepared from hybridoma cells in our
lab) (Singh and Gupta 1992). As a loading control, mouse
anti-human α-tubulin antibody (from Santa Cruz Biotech-
nology, Santa Cruz, CA, USA; catalogue number: sc-23948)
was used. Polyclonal rabbit anti-mouse immunoglobulins,
covalently bound to horseradish peroxidase (P0161, Dako,
Glostrup, Denmark) as secondary antibody, allowed for de-
tection of the signal with the ECL method (Pierce, Rockford,
IL, USA).
Table 1 List of the RT-PCR
primer pairs
HSPD1 gene coding for hHsp60,
EGR-1 early growth response
protein 1, ICAM-1 intracellular
adhesion molecule 1, VCAM-1
vascular cell adhesionmolecule 1,
MCP-1 monocyte chemotactic
protein 1, IL interleukin, TF tissue
factor, SOD1 superoxide dismu-
tase 1 (Cu-Zn), TRX-1 thiore-
doxin 1, COX cyclooxygenase,
NOX nicotinamide adenine
dinucleotide phosphate oxidase,
SDHA subunit A of the succinate
dehydrogenase complex
Gene title Forward Reverse
HSPD1 CCACTGCTACTGTACTGGCAC AGCTAACATCACACCTCTCCT
EGR-1 AAGCAAACCAATGGTGATCC TGCCACATGTGAGAGTACGG
ICAM-1 CTGCAGACAGTGACCATC GTCCAGTTTCCCGGACAA
VCAM-1 GGTTTCTCTGTATAGTACTGGCATG TCATCAGACTCCTGTGCAACTTT
E-selectin GAGGAATGCCTGTGTGAGCA CCAAAGGAATCTCCAGTTTTCAGT
MCP-1 CAAGCAGAAGTGGGTTCAGGAT AGTGAGTGTTCAAGTCTTCGGAGTT
IL-6 TTCTCCACAAGCGCCTTCGGTCCA AGGGCTGAGATGCCGTCGAGGATGTA
IL-8 TCTCTTGGCAGCCTTCCTGATTTC GTGTGGTCCACTCTCAATCACTCT
TF CCGAACAGTTAACCGGAAGA TCAGTGGGGAGTTCTCCTTC
SOD1 AGGGCATCATCAATTTCGA TCCAGAAAACACGGTGGG
TRX-1 GGCTTGATCATTTTGCAAGG GTCAGACTCCAGCAGCCAAG
COX-1 GAACATGGACCACCACATCC TTTCATGCCAAACCTCTTGC
COX-2 GCAGGGTTGCTGGTGGTAG ATTTCATCTGCCTGCTCTGG
NOX-2 CAAGATGCGTGGAAACTACCTAAGAT TCCCTGCTCCCACTAACATCA
NOX-4 CTGCTGACGTTGCATGTTTC TTCTGAGAGCTGGTTCGGTT
SDHA TGGGAACAAGAGGGCATCTG CCACCACTGCATCAAATTCATG
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Immunofluorescence staining of cells and confocal
microscopy
For immunofluorescence analysis, HUVECs, AECs, and
VECs were grown in RPMI medium (Lonza) on 18×18 mm
glass coverslips (Nunc, Rochester, NY, USA) coated with
10 % gelatine (Sigma-Aldrich, St. Louis, MO, USA). Cells
were washed with phosphate-buffered saline (PBS), pH 7.2,
fixed, and permeabilized with 99.5 % acetone at −20 °C for
2.5 min for intracellular staining. Subsequently, cells were
allowed to dry for 30 min at room temperature (RT), followed
by blocking with 0.1 % bovine serum albumin (Sigma-
Aldrich) in PBS for 30 min at RT. For surface staining, cells
were kept for all steps at 4 °C and fixed with 4 % paraformal-
dehyde after incubation with the antibodies. Identical blocking
solution and reagents were used for both staining protocols.
Staining of eukaryotic HSP60 was performed with either the
mouse anti-human HSP60 antibody (clone II-13) or rabbit
anti-human HSP60 antibody (sc-13966, Santa Cruz Biotech-
nology). Staining of chlamydial HSP60, human intracellular
adhesion molecule 1 (ICAM-1), and human vascular cell
adhesion molecule 1 (VCAM-1) was performed using mouse
anti-chlamydial HSP60 antibody (Stressgen, Enzo Life Sci-
ences, Plymouth Meeting, PA, USA), mouse anti-human
ICAM-1, and mouse anti-human VCAM-1 antibodies (both
e-Bioscience, San Diego, CA, USA). The matching isotype
control antibodies were from Dako. After four washing
steps with PBS, staining was visualized using either goat
anti-mouse IgG Alexa 488- or Alexa 568- and goat anti-
rabbit Alexa 568-labeled secondary antibodies (Invitrogen,
Carlsbad, CA, USA). Cells were then washed again, nuclei
were stained with Hoechst 33342 (Sigma-Aldrich) accord-
ing to the manufacturer’s protocol, and the coverslips were
mounted with Fluoromount G on to the specimen holder
(Nunc, Rochester, NY, USA). Time-resolved 3D stacks
were acquired with an SP5 confocal microscope (Leica
Microsystems, Wetzlar, Germany) equipped with a fast
resonant scanner. We used an HCX PL APO lambda blue
×63 1.4 NA oil immersion objective. Imaging was per-
formed with a 476-nm laser line for EGFP, a 561-nm laser
line for AlexaFluor568 and mCherry excitation, and
633 nm for AlexaFluor647. Fluorescence emission was
detected from 493 to 555 nm (EGFP), 566 to 742 nm
(AlexaFluor568, mCherry), and 638 to 750 nm
(AlexaFluor647). Images were acquired using the LAS
AF acquisition software Version 2.1.
OxyBlot analysis of oxidative protein modification
To assess the formation of protein carbonyl groups as a mea-
sure of oxidative protein modification, the OxyBlot protein
oxidation detection kit (Millipore, S7150) was used according
to the manufacturer’s detailed protocol. For OxyBlot analysis,
107 cells were washed twicewith cold PBS and lysed (150mM
NaCl, 0.1 % Triton X-100, 30 mM Tris, 1 mM PMSF, 10 %
glycerol, peptide inhibitors) on ice for 15 min. The cellular
debris was removed by centrifugation (10,000×g, 4 °C,
15 min). The supernatant was incubated with 2 μg of the
respective antibodies and 40 μl of protein A/protein G agarose
mix (Oncogene Research Products, Darmstadt, Germany) on a
shaker for 2 h at 4 °C. Bound proteins were collected by
centrifugation. The pellet was washed four times in lysis
buffer, and subsequently suspended in “carbonyl-moiety to
dinitrophenylhydrazone (DNP)-derivative converting solu-
tion.” After washing in Tris-buffered saline, the pellets were
suspended for electrophoretic separation in Western blot load-
ing buffer. The separated DNP-containing proteins were
detected in Western blots (with DNP-specific antibodies) as
described (Bernhard et al. 2005).
Statistics
Data are presented as mean ± SD. Statistical analyses were
performed using computer software (SPSS 17.0). Variable
levels between different treatment groups were compared
using ANOVA.
Results
Infection with C. pneumoniae leads to upregulation
of hHSP60 and its relocalization to the endothelial cell surface
Based on our previous finding of increased hHSP60 expres-
sion in vascular endothelial cells in the presence of a diverse
range of pro-atherogenic stimuli, we examined the effect of
chlamydial infection on expression of hHSP60 in endothe-
lial cells. As shown in Fig. 1a, chlamydial infection of
HUVECs led to a significantly increased expression of
hHSP60 mRNA with a maximum of expression at 6 h. As
determined by Western blot analysis, hHSP60 levels were
markedly increased upon infection with C. pneumoniae
(Fig. 1b) with a peak of expression at 24 h (more than
twofold upregulation). RT-PCR and Western blot analyses
showed increased hHsp60 mRNA and protein expression,
respectively, in C. pneumoniae-infected HUVECs, but this
approach did not allow any conclusions about the subcellu-
lar localization of the HSP60 molecules. Therefore, confocal
microscopy of primary adult endothelial cells was per-
formed (Fig. 2), clearly showing in AECs (Fig. 2a) redistri-
bution of hHSP60 from the mitochondria to the plasma
membrane together with adhesion molecules. Interestingly,
neither hHSP60 surface expression nor hHSP60 presence
was visible in the autologous VECs (Fig. 2b). As shown in
Fig. 2c, surface expression of hHSP60 was accompanied by
pronounced accumulation of intracellular chlamydial
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particles (cHSP60 staining) demonstrating successful infec-
tion of endothelial cells in our experimental setting.
Infection with C. pneumoniae leads to increased expression
of chemokines and adhesion molecules in endothelial cells
Early atherosclerotic lesions are characterized by the presence
of activated T cells and monocyte-derived macrophages.
Importantly, lymphocyte and monocyte trafficking is highly
dependent on chemoattractant chemokines produced at sites
of ongoing inflammation. As outlined in Fig. 3, analysis by
RT-PCR revealed pronounced upregulation of MCP-1 and IL-
8 in endothelial cells, which are known to be the most potent
chemokines for macrophage migration. Moreover, expression
of adhesion molecules ICAM-1, VCAM-1, and E-selectin
was increased starting at 3 h, with a peak of expression
reached at 6 h post-infection. An increased expression of all
the investigated adhesion molecules was sustained for up to
24 h post-infection (Fig. 3). Additionally, we found the tran-
scription factor early growth response gene-1 (Egr-1), a key
mediator of inflammation and gene expression after vascular
injury, to be markedly upregulated at early time points of
infection (Fig. 4a).
Infection with C. pneumoniae leads to a pro-coagulative
state in endothelial cells
Besides its role in the gradual process of atherosclerotic
lesion formation, chlamydial infection has been suggested
to play a role in acute vascular events such as acute coronary
syndrome. In the present study, infection with C. pneumo-
niae led to upregulation of tissue factor (TF) (Fig. 4b).
Increased expression of TF would facilitate onset of the
external pathway of blood coagulation and, thus, enhance
the risk of acute vascular thrombosis.
C. pneumoniae-infected endothelial cells show evidence
of increased oxidative stress
The cellular redox state plays a key role in several cellular fate
decisions ranging from regulation of genes and redox-
sensitive pathways to triggering cell death mechanisms. To
get a deeper insight into the molecular mechanisms involved
in the pro-atherosclerotic activities of C. pneumoniae, we
examined if the endothelial redox balance was affected by
C. pneumoniae infection by measuring the levels of protein
carbonyl formation with the OxyBlot-based technique. C.
pneumoniae-infected cells showed increased levels of protein
carbonyl moieties as compared to noninfected cells (Fig. 5).
To determine the pathophysiological significance, if any, of
this finding, we treated cells with various antioxidants before
Fig. 1 qRT-PCR analysis of human HSP60 (hHSP60) expression in
HUVECs infected with C. pneumoniae. Control: succinate dehydroge-
nase (SDHA). Mean ± SD, n03. Relative change in expression of the
target gene mRNA is shown in relation to untreated samples with SDHA
serving as an internal control (a). Western blot analysis of hHSP60
expression in HUVECs infected with C. pneumoniae for the given time
points. Shown is one representative experiment out of three (b)
Fig. 2 Confocal microscopy. Human HSP60 (hHsp60) stained at the cell
surface of nonpermeabilized cells (a, b). Orthogonal view of a z-stack of
donor matched primary endothelial cells (48 h post-C. pneumoniae
infection). ICAM (red), hHSP60 (green). Bar05 μm. AECs (a) or VECs
(b). Chlamydial HSP60 (cHSP60) in C. pneumoniae-infected HUVECs,
permeabilized for intracellular staining. Maximum intensity projection of
HUVEC (z-stack, 48 h post-C. pneumoniae infection). cHSP60 (green),
hHSP60 (red). Bar05 μm (c)
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infection with C. pneumonia. Figure 6a shows that the pres-
ence of both the broad spectrum antioxidant N-acetylcysteine
and the superoxide anion scavenger tiron (4,5-dihydroxy-1,3-
benzene disulfonic acid) significantly attenuated the inflam-
matory response of endothelial cells upon C. pneumoniae
infection. Taken together, these results strongly suggest that
redox-sensitive signaling pathways mediate the upregulation
of genes relevant for vascular inflammation.
C. pneumoniae infection causes downregulation
of thioredoxin and superoxide dismutase and increased
expression of NADPH oxidase
Based on the finding of an increased ROS production in C.
pneumoniae-infected cells, we investigated whether chla-
mydial infection has an impact on the antioxidative defense
systems of endothelial cells. We found the expression of
thioredoxin-1 (TRX-1), a major antioxidative defense sys-
tem in endothelial cells, and superoxide dismutase-1 (SOD-
1) to be strongly downregulated. Concomitantly, the proto-
typical endothelial NADPH oxidase-4 (NOX-4) and
NADPH oxidase-2 (NOX-2), the two major sources of
ROS in the vasculature (Lassègue and Griendling 2010),
were upregulated, pointing towards a redox imbalance with-
in C. pneumoniae-infected cells. Furthermore, our experi-
ments showed increased expression of the ROS-producing
enzyme cyclooxygenase-2 (COX-2) but not of COX-1 upon
chlamydial infection pointing towards an additional role of
COX-2 in the increased cellular ROS level associated with
C. pneumoniae infection (Fig. 6b).
Discussion
The most striking finding in our study was the observation
of upregulation and surface expression of hHSP60 in arterial
endothelial cells upon chlamydial infection. Of note, AECs
proved to be markedly more susceptible to a chlamydia-
mediated stress reaction in terms of surface expression of
hHSP60 as compared to VECs from the same donors, which
might be explained by the lifelong exposure of AECs to
arterial blood pressure and flow conditions. This finding
places C. pneumoniae among acquired primary stress fac-
tors, especially for AECs, and is in agreement with our
notion of a T-cell-mediated immunopathology underlying
the atherosclerotic process. Expression of hHSP60 on the
surface of endothelial cells might represent a major target
for pre-existing hHSP60 auto- and cross-reactive immunity
(Wick 2000). The nonphysiological expression of such an
intracellular antigen on the cell surface of stressed arterial
endothelial cells would lead to a vicious cycle of infiltration
of the vascular wall by cross-reactive T cells and destruction
Fig. 3 RT-PCR analysis of adhesion molecules and pro-inflammatory
cytokines in HUVECs. Cells were subjected to C. pneumoniae infec-
tion for the indicated time periods. Mean ± SD, n03. Relative change
in expression of the target gene mRNA is shown in relation to untreat-
ed samples with SDHA serving as an internal control
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of stressed endothelial cells (Curry et al. 2000). A study
investigating the clonality of such atherosclerotic plaque-
derived T cells in cohorts of both anti-C. pneumoniae sero-
positive and seronegative patients found plaques of seroneg-
ative patients to harbor clones of T cells that recognize
hHSP60 epitopes, while in seropositive patients, these T cells
were found to cross-react with cHSP60 due to molecular
mimicry of certain HSP60 epitopes (Benagiano et al. 2005).
This observation is in agreement with the finding of our
previous cross-sectional studies, namely, that T-cell reactivity
to bacterial and human HSP60 is an independent risk factor
for incipient atherosclerosis in a cohort of clinically healthy
young adults (Knoflach et al. 2007; Rossmann et al. 2008;
Knoflach et al. 2009). As HSP60 constitutes a highly con-
served molecule, there is significant homology in the protein
structure of human and bacterial HSP60 (Young and Elliott
1989). Lifelong reactivation of chlamydial infection in the
vasculature (Peters et al. 2005) would lead to a chronic im-
mune reaction against cHSP60 and would significantly in-
crease the risk for immunological cross-reactivity of human
chlamydia-specific T cells against stressed AECs. Besides
recruitment of cross-reactive T cells, increased IL-8 and
MCP-1 production paralleled by expression of adhesion mol-
ecules as demonstrated in the present and other studies points
to increased trafficking of monocytes into the vascular wall
(Krüll et al. 1999; Molestina et al. 1999; Kothe et al. 2000;
Hogdahl et al. 2008). Besides being a causative agent of
systemic and local inflammation, chlamydial particles appear
to be potent inducers of a pro-coagulative state of the physi-
ologically inert vasculature. Our finding of increased endo-
thelial TF expression early after chlamydial infection suggests
an increased risk for acute thrombotic events in people sub-
jected to chlamydial infection. An in vivo relevance of this
finding is suggested by Hoshida et al. (2005) who found
serum levels of anti-chlamydial IgM and hHSP60 antibody
levels to be significantly higher in acute coronary syndrome
patients as opposed to a clinically stable control cohort.
In the present study, several major pro-atherogenic
changes observed upon chlamydial infection in HUVECs
were found to depend on increased production of ROS,
since application of antioxidants markedly ameliorated the
endothelial stress response in the presence of C. pneumonia.
Transcriptional upregulation of COX-2 as well as NOX-2
and NOX-4 paralleled by downregulation of SOD-1 and
TRX-1 demonstrates a shift toward a more oxidative cellular
redox state. COX-2 is involved in various inflammatory
processes including atherosclerosis, and its inhibition was
shown to significantly ameliorate C. pneumoniae-mediated
effects on vascular remodeling (Rupp et al. 2004). Thus,
chlamydial infection causes a remarkable redox imbalance
in the host cell, with a diminished antioxidative defense on
Fig. 5 Endothelial cells infected with C. pneumoniae show evidence
of increased oxidative stress. OxyBlot analysis of proteins from unin-
fected control (Ctrl) and C. pneumoniae-infected (C.pn.) HUVECs (3
and 6 h after infection). Representative images of three independent
experiments are shown
Fig. 4 RT-PCR analysis of the early growth response gene-1 (Egr-1) in
C. pneumoniae-infected HUVECs. Cells were subjected to C. pneumo-
niae infection for the indicated time periods. Short but pronounced
upregulation of Egr-1 mRNA occurs as an early event at 1 h after
infection. Mean ± SD, n03 (a). RT-PCR analysis of human tissue factor
(TF) in HUVECS infected with C. pneumoniae. Mean ± SD, n03 (b).
Relative change in expression of the target gene mRNA is shown in
relation to untreated samples with SDHA serving as an internal control
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the one hand and critical enhancement of ROS-levels with
upregulated NOX-2 and NOX-4 genes on the other.
In a recent study, it has been shown that LPS induces a
superoxide-dependent expression of inflammatory cytokines
and prostaglandins via upregulation of NADPH oxidase in a
rat model of hypertension (Zhang et al. 2010). Besides LPS-
mediated signaling events, cHSP60 has been found to directly
cause endothelial dysfunction by downregulation of endothe-
lial nitric oxide synthase and associated mitochondrial dys-
function in human coronary artery endothelial cells, and
application of antioxidants was shown to abrogate HSP60-
mediated endothelial dysfunction (Chen et al. 2009). Our
finding of an increased oxidative state is in agreement with
previous studies that could demonstrate increased levels of
ROS in smooth muscle cells subsequent to infection with C.
pneumoniae that seemed to depend on a functional NADPH
oxidase activity (Dechend et al. 2003). A contributory role of
superoxide anion in this process is suggested by our finding of
downregulation of SOD-1 (Fig. 6b) as an early event after C.
pneumoniae infection and by the markedly reduced endothe-
lial stress response to C. pneumoniae infection in the presence
of the superoxide radical scavenger tiron (Fig. 6a). This find-
ing suggests that antioxidant therapy might hold promise as a
preventive measure against atherogenesis in the presence of
risk factors such as infection with C. pneumoniae.
In summary, the finding of a markedly increased sus-
ceptibility of arterial endothelial cells as compared to
venous endothelial cells from the same donor for redistri-
bution and enrichment of hHSP60 on the cellular surface
further lends support to our hypothesis of atherosclerosis
being the result of immunological cross-reactivity against
eukaryotic hHSP60 under stressful conditions. Our data
extend the list of established stress factors for endothelial
cells that all converge upon the immunological danger
signal hHSP60 being exposed on the cell surface. Com-
pared to the data of previous studies on the degree of
endothelial cell stressing capacity of canonical risk factors
of atherosclerosis as reflected by the abundant expression
of hHSP60, C. pneumoniae emerged as the most potent
endothelial cell stressor (Amberger et al. 1997; Henderson
et al. 2008; Wick et al. 2008; Grundtman et al. 2011). The
cross-recognition of shared epitopes between human and
chlamydial HSP60 by autoreactive cellular and humoral im-
munity might represent an as yet unappreciated mechanism
underlying the atherogenic potential of recurrent infection or
reactivation of chlamydial particles in patients who fail to
clear the infection. We believe that further in vivo studies are
warranted to delineate the association of persistent chlamydial
infection with markers of systemic inflammation in order to
design novel therapeutic approaches aimed at counteracting
Fig. 6 RT-PCR analysis of
adhesion molecules and
pro-inflammatory cytokines in C.
pneumoniae-infected HUVECs
in the presence of antioxidants.
Cells were pre-incubated either
with the superoxide radical
scavenger tiron or
N-acetylcysteine (NAC) for
30 min and infected with C.
pneumoniae for 6 h. Mean ± SD,
n03. (*P<0.05) (a). RT-PCR
analysis of ROS-producing
enzymes in HUVEC subjected to
C. pneumoniae infection.
HUVECs infected with
C. pneumoniae show transient
upregulation of the NADPH
oxidase isoforms NOX-2 and
NOX-4 at 1 h, while upregulation
of COX-2 persists at 6 h, when
downregulation of TRX-1 as
well as SOD-1 is detected.
Mean ± SD, n03 (b). Relative
change in expression of the target
gene mRNA is shown in relation
to untreated samples with
SDHA serving as an internal
control
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endothelial cell activation and associated vascular autoim-
mune pathogenic mechanisms.
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